학술논문

Prevalence of Mycoplasma genitalium infection, antimicrobial resistance mutations and symptom resolution following treatment of urethritis
Document Type
article
Source
Clinical Infectious Diseases. 71(10)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Oncology and Carcinogenesis
Sexually Transmitted Infections
Clinical Research
Clinical Trials and Supportive Activities
Infectious Diseases
Urologic Diseases
Antimicrobial Resistance
Infection
Good Health and Well Being
Anti-Bacterial Agents
Drug Resistance
Bacterial
Female
Humans
Macrolides
Male
Mutation
Mycoplasma Infections
Mycoplasma genitalium
Prevalence
Urethritis
urethritis
resistance
persistence
MAGNUM Laboratory Working Group
Mycoplasma genitalium
Biological Sciences
Medical and Health Sciences
Microbiology
Clinical sciences
Language
Abstract
BackgroundAntimicrobial resistance in Mycoplasma genitalium (MG), a cause of urethritis, is a growing concern. Yet little is known about the geographic distribution of MG resistance in the United States or about its associated clinical outcomes. We evaluated the frequency of MG among men with urethritis, resistance mutations, and posttreatment symptom persistence.MethodsWe enrolled men presenting with urethritis symptoms to 6 US sexually transmitted disease (STD) clinics during June 2017-July 2018; men with urethritis were eligible for follow-up contact and, if they had persistent symptoms or MG, a chart review. Urethral specimens were tested for MG and other bacterial STDs. Mutations in 23S ribosomal ribonucleic acid (rRNA) loci (macrolide resistance-associated mutations [MRMs]) and in parC and gyrA (quinolone-associated mutations) were detected by targeted amplification/Sanger sequencing.ResultsAmong 914 evaluable participants, 28.7% (95% confidence interval [CI], 23.8-33.6) had MG. Men with MG were more often Black (79.8% vs 66%, respectively),